editorinchief@ijsreat.com +91 9840521421 Scholarly Open Access, Peer-reviewed, Refereed Journal e-ISSN 2583-1240 Since 2021
  1. Home
  2. Archives
  3. 2026
  4. Vol. 6 Issue 3
  5. Article
Original Article

AI-Based Neurodegenerative Disease Risk Screening System: A Multi-Disease Symptom-Driven Machine Learning Framework with Time-Progression Simulation

  • Paper ID 310
  • Volume 6, Issue 3
  • Pages 01-04
  • Published Online: May-June 2026
  • 209 Views
Open Access Peer Reviewed

Authors

  • A. Ruba1
  • S. Aahila Parveen2
  • M. Abarna3
  • M. Kaviya4
  • R. Sandhiya5

1 Associate Professor, Department of Artificial Intelligence and Data Science, Mohamed Sathak Engineering College, Kilakarai, Tamil Nadu, India. 2 3 4 5 Student, Department of Artificial Intelligence and Data Science, Mohamed Sathak Engineering College, Kilakarai, Tamil Nadu, India.

Article Information

DOI
No DOI
Published Online
May-June 2026
Pages
01-04
Article Type
Original Article
Check for updates
No DOI available for cross-reference

Abstract

View PDF

Neurodegenerative diseases including Alzheimer's, Parkinson's, and Huntington's disease represent a growing global health crisis, affecting millions worldwide and placing enormous burden on healthcare systems. Early detection remains a critical challenge due to the complexity and symptom overlap among these conditions. This paper presents a comprehensive AI-Based Neurodegenerative Disease Risk Screening System designed to assist in early identification of neurological disease risk through machine learning-based prediction. The system utilizes a synthetic clinical dataset encompassing key parameters including age, memory loss, movement issues, speech problems, family history, and symptom duration. A Random Forest classifier trained on this dataset achieved 93% overall accuracy in predicting the likelihood of three neurological conditions. The system integrates a Time Progression Simulation module projecting disease risk across 6-month, 8- month, and 12-month horizons, and generates a structured clinical-style risk report with explainable AI output. Extensive evaluations confirm high throughput, low response latency (1.2 seconds average), and strong classification performance across all three disease classes.

APC from ₹1200 + 18% GST

Peer-reviewed open access₹1200 Indian (₹1400 with DOI)$80 USD internationalpaid after acceptance Peer-reviewed open access₹1200 Indian$80 USD international ₹1200 Indian · $80 intl

  • CrossRef DOI
  • ISSN 2583-1240
  • Open Access
  • Peer Reviewed
  • Plagiarism Checked
  • Google Scholar
Submit Paper